VistaGen Therapeutics VTGN
$ 3.08
-0.32%
Quarterly report 2024-Q2
added 08-13-2024
VistaGen Therapeutics Cash Flow 2011-2024 | VTGN
Annual Cash Flow VistaGen Therapeutics
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-25.8 M | -49.7 M | -45.3 M | -12.1 M | -15.8 M | -14.5 M | -9.06 M | - | - | -2.77 M | -2.13 M | -3.46 M | -3.57 M | -841 K |
Depreciation & Amortization |
127 K | 130 K | 154 K | 118 K | 103 K | 91.2 K | 80.7 K | 54.9 K | 53.5 K | 59.1 K | 54.6 K | 33.8 K | 45.6 K | 45.3 K |
Accounts Payables |
1.55 M | 2.47 M | 2.76 M | 838 K | 1.84 M | 1.06 M | 1.2 M | 867 K | 936 K | 2.25 M | 2.44 M | 1.35 M | 1.75 M | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | 2.8 K | - | 106 K | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow VistaGen Therapeutics
2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-10.9 M | - | - | -7.89 M | - | - | -42.2 M | -16 M | - | - | -29.7 M | -17.6 M | - | - | -6.79 M | -1.8 M | -2.81 M | - | -13.2 M | -8.9 M | -4.76 M | - | -11 M | -7.06 M | - | - | - | -2.13 M | - | - | -5.97 M | -3.87 M | - | - | -3.5 M | -2.33 M | - | - | -1.87 M | -1.53 M | - | - | -1.66 M | -1.32 M | - | - | -2.49 M | -1.53 M | - | - | -2.85 M | -1.79 M | - |
Depreciation & Amortization |
34 K | - | - | 32 K | - | 30.6 K | 96.2 K | 32.3 K | - | 43.7 K | 115 K | 71.2 K | - | 26.4 K | 25.5 K | 25.4 K | - | 25.5 K | 77.6 K | 52.1 K | 26.2 K | - | 64.8 K | 37.9 K | - | - | - | 23.6 K | - | - | 37.6 K | 26 K | - | - | 40.8 K | 28.9 K | - | - | 39.2 K | 26.2 K | - | - | 40.2 K | 25.8 K | - | - | 21 K | 11.8 K | - | - | 33.5 K | 21.3 K | - |
Accounts Payables |
1.21 M | 1.74 M | 1.3 M | 1.62 M | 2.47 M | 1.6 M | 2.96 M | 5.47 M | 2.76 M | 1.95 M | 2.66 M | 2.32 M | 838 K | 776 K | 1.18 M | 1.31 M | 1.84 M | 1.61 M | 1.45 M | 934 K | 1.06 M | 1.09 M | 590 K | 630 K | 1.2 M | 509 K | 1.15 M | 632 K | 867 K | 874 K | 930 K | 930 K | 936 K | 1.1 M | 1.11 M | 1.55 M | 2.25 M | 2.42 M | 2.25 M | 1.9 M | 2.44 M | 2.26 M | 1.98 M | 1.76 M | 2.44 M | 1.25 M | 1.47 M | 2.56 M | 1.35 M | 1.04 M | 1.24 M | 943 K | 1.77 M |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.25 M | - | - | - | - | - | - | - | - | 2 K | 5.3 K | 2.8 K | 2.8 K | 2.8 K | 2.8 K | - | - | 1.6 K | 1.6 K | 106 K | 7.78 K | 127 K | 149 K | 42.2 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency